ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
7,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
9,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
11,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
11,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11,5,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
11,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,7,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
11,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
11,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11,14,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
11,15,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11,16,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
12,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
12,2,Acne,Acnes,Skin appendage conditions,Skin,N
12,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
12,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
12,5,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
12,6,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
12,7,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
12,8,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
12,9,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,11,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
12,12,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
12,13,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
12,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
12,15,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,16,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
12,17,Neglect of personal appearance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
12,18,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,19,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,20,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,21,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
12,22,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12,23,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
12,24,Red blood cell sedimentation rate decreased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
12,25,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,26,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
12,27,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
12,28,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
12,29,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
12,30,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,31,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
12,32,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,33,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
13,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
13,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
13,6,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
13,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,8,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
14,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
15,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
